Infliximab-induced liver injury: Clinical phenotypes, autoimmunity and the role of corticosteroid treatment.

Title
Infliximab-induced liver injury: Clinical phenotypes, autoimmunity and the role of corticosteroid treatment.
Authors
Keywords
DILI, drug-induced liver injury, hepatotoxicity, liver enzymes, steroids
Journal
JOURNAL OF HEPATOLOGY
Volume -, Issue -, Pages -
Publisher
Elsevier BV
Online
2021-09-03
DOI
10.1016/j.jhep.2021.08.024

Ask authors/readers for more resources

Reprint

Contact the author

Add your recorded webinar

Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.

Upload Now

Ask a Question. Answer a Question.

Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.

Get Started